Valuation: JBCHEMICAPAR

Market Cap 387B 4.06B 3.52B 3.27B 3.02B 5.68B 5.79B 38.74B 15.17B 192B 15.23B 14.9B 647B P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 387B 4.06B 3.52B 3.27B 3.02B 5.68B 5.79B 38.74B 15.17B 192B 15.23B 14.9B 647B EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.73%
Current month+5.09%
1 month+4.80%
3 months+16.93%
6 months+30.76%
Current year+32.51%
1 month 2,270
Extreme 2270
2,509.4
Current year 1,777.05
Extreme 1777.05
2,509.4
1 year 1,603.05
Extreme 1603.05
2,509.4
3 years 1,203.8
Extreme 1203.8
2,509.4
5 years 669.52
Extreme 669.525
2,509.4
10 years 118
Extreme 118
2,509.4
Date Insider Type Main position Quantity % Market Cap.
22/9/25 Sell

Chief Executive Officer

24,785 0.0159%
22/9/25 Sell

Chief Executive Officer

19,312 0.0124%
15/9/25 Sell

Chief Executive Officer

965 0.0006%

Financials

2027 *2028 *
Net sales 47.6B 499M 433M 402M 371M 699M 711M 4.76B 1.86B 23.64B 1.87B 1.83B 79.51B 54.41B 570M 495M 460M 424M 799M 813M 5.44B 2.13B 27.02B 2.14B 2.09B 90.87B
Net income 9B 94.24M 81.86M 76.02M 70.11M 132M 134M 900M 352M 4.47B 354M 346M 15.03B 11.85B 124M 108M 100M 92.36M 174M 177M 1.19B 464M 5.89B 466M 456M 19.8B
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,307.12INR
Spread / Average Target
-4.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. JBCHEPHARM Stock